AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 41,450
-1,650 (-3.83%)
At close: Jun 12, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 970.5 billion as of June 12, 2026. Its market cap has increased by 151.66% in one year.
Market Cap
970.50B
Enterprise Value
888.00B
Revenue
725.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
41,450.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 970.50B, an increase of 322.42%. That is a compound annual growth rate of 45.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 970.50B | -23.83% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.76T |
| Rznomics | 1.29T |
| JS Link | 1.14T |
| Qurient | 1.10T |
| ROKIT Healthcare | 799.35B |
| Inventage Lab | 589.51B |
| Curocell | 435.46B |
| IMBiologics | 398.23B |